文献速递医学教育与科研方法临床试验与 GCP

中药随机对照试验文献质量评估系统的构建与评价

Evaluation of randomized controlled trial literature in traditional Chinese medicine: a literature quality assessment system.
PubMed 文献 · Trials · 2026-03-21

本研究整合国际标准与中医药特色,构建了针对中药随机对照试验(RCT)的文献质量评估系统,并对2776项中药RCT进行评价。结果显示,关键方法学要素如中医诊断依据、证候、随机化方法和盲法常被遗漏,遗漏率为68.58%至97.48%,提示中药RCT设计存在严重问题。

要点

  • 中药RCT中中医诊断依据、证候、随机化方法和盲法遗漏率高(68.58%-97.48%)。
  • 结局指标和参与者医疗来源提及常见但描述模糊,准确率分别为60.73%和74.52%。
  • 治疗组干预完整性(97.83%)高于对照组(82.68%),不准确常源于干预描述不完整或药物成分未说明。

核心结论

  • 中药RCT设计中常缺失中医相关概念,可能阻碍中医理论发展。
  • 不准确的试验设计和干预描述可为未来中药RCT方案或报告提供警示。

研究设计与样本

  • 整合国际标准与中医药特色,创建评估基本方法信息和干预操作的清单。
  • 建立评级系统,根据完整性和准确性将内容分为四类。
  • 评估了六类疾病的2776项中药RCT。

主要发现

  • 结局指标和参与者医疗来源的准确率分别为60.73%和74.52%。
  • 中医诊断与诊断依据、中医证候、随机化方法和盲法的遗漏率范围为68.58%至97.48%。
  • 治疗组干预完整性为97.83%,对照组为82.68%。
  • 报告不准确常源于干预描述不完整或药物成分未说明。

临床怎么用

  • 未来中药RCT方案和报告应参考本评估系统,避免类似设计缺陷。
  • 应特别关注中医诊断依据、证候、随机化方法和盲法的完整报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have evaluated traditional Chinese medicine (TCM) clinical randomized controlled trial (RCT) literature broadly, but they have provided limited depth in evaluating the specific aspects of trial quality. OBJECTIVE: This study aims to develop a specialized literature quality assessment system for TCM RCTs. METHODS: We integrated international standards with TCM characteristics to create a checklist for evaluating basic method information and intervention operations. A rating system was established to classify content into four categories based on completeness and accuracy. RESULTS: We assessed 2776 TCM RCTs across six disease categories. For basic method information, "outcome indicators" and "participants' medical sources" were commonly mentioned but often vague, with accurate rates of 60.73% and 74.52%, respectively. Critical elements, including "TCM diagnosis and diagnostic basis," "TCM syndromes (clinically defined patterns of symptoms that guide TCM therapy)," "randomization methods," and "blinding" were frequently omitted, with omission rates ranging from 68.58% to 97.48%. For interventions, "treatment group intervention" had higher completeness (97.83%) than "control group intervention" (82.68%). Inaccurate reporting commonly stemmed from incomplete descriptions of interventions or unspecified drug compositions. CONCLUSION: Our results suggested a serious concern that TCM-related concepts were often missing in trial designs for TCM RCTs, which might impede the development of TCM theories. Also, this study's inaccurate trial designs and intervention descriptions can provide cautionary examples for future RCT protocols or reports in TCM to avoid.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Liu H, Jiang G, et al. Evaluation of randomized controlled trial literature in traditional Chinese medicine: a literature quality assessment system. Trials. 2026. PMID: 41864955. doi:10.1186/s13063-026-09599-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。